OVA Conjugated Gastric Inhibitory Polypeptide (GIP)
Incretin hormone; Glucose Dependent Insulinotropic Peptide
- Product No.CPA882Hu21
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- SourceProtein conjugation
- Original Molecular Massn/a
- Buffer FormulationPBS, pH7.4.
- TraitsFreeze-dried powder
- Purity> 90%
- Isoelectric Pointn/a
-
Applications
Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein. - Download Instruction Manual
- UOM 10µg50µg 200µg 1mg 5mg
-
FOB
US$ 120
For more details, please contact local distributors!US$ 300
For more details, please contact local distributors! US$ 600
For more details, please contact local distributors! US$ 1800
For more details, please contact local distributors! US$ 4500
For more details, please contact local distributors!
-
Packages (Simulation)
-
Packages (Simulation)
-
Mass spectrometry
-
-
ISO9001: 2008, ISO13485: 2003 Registered
FORMULA of the OVA Conjugated Gastric Inhibitory Polypeptide (GIP)
USAGE of the OVA Conjugated Gastric Inhibitory Polypeptide (GIP)
Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE of the OVA Conjugated Gastric Inhibitory Polypeptide (GIP)
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY of the OVA Conjugated Gastric Inhibitory Polypeptide (GIP)
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
INCREMENT SERVICES
Related products
GUESTBOOK